[1] Cattaneo E, Zuccato C, Tartari M. Normal huntingtin function: An alternative approach to huntington's disease [J]. Nat Rev Neurosci, 2005, 6(12): 919-930.
[2] A novel gene containing a trinucleotide repeat that is expanded and unstable on huntington's disease chromosomes. The huntington's disease collaborative research group [J]. Cell, 1993, 72(6): 971-983.
[3] Warby SC, Doty CN, Graham RK, et al. Activated caspase-6 and caspase-6-cleaved fragments of huntingtin specifically colocalize in the nucleus [J]. Hum Mol Genet, 2008, 17(15): 2390-2404.
[4] Ross CA, Aylward EH, Wild EJ, et al. Huntington disease: Natural history, biomarkers and prospects for therapeutics [J]. Nat Rev Neurol, 2014, 10(4): 204-216.
[5] Fang F, Peng T, Yang SM, et al. Lycium barbarum polysaccharide attenuates the cytotoxicity of mutant huntingtin and increases the activity of akt [J]. Int J Dev Neurosci, 2016, 52(4): 66-74.
[6] Menalled LB, Sison JD, Wu Y, et al. Early motor dysfunction and striosomal distribution of huntingtin microaggregates in huntington's disease knock-in mice [J]. J Neurosci, 2002, 22(18): 8266-8276.
[7] Imarisio S, Carmichael J, Korolchuk V, et al. Huntington's disease: From pathology and genetics to potential therapies [J]. Biochem J, 2008, 412(2): 191-209.
[8] Ayala-Pena S. Role of oxidative DNA damage in mitochondrial dysfunction and huntington's disease pathogenesis [J]. Free Radic Biol Med, 2013, 62(9): 102-110.
[9] Pelegri C, Duran-Vilaregut J, del Valle J, et al. Cell cycle activation in striatal neurons from huntington's disease patients and rats treated with 3-nitropropionic acid [J]. Int J Dev Neurosci, 2008, 26(7): 665-671.
[10]Li XJ, Li H, Li S. Clearance of mutant huntingtin [J]. Autophagy, 2010, 6(5): 663-664.
[11]Ciechanover A. Proteolysis: From the lysosome to ubiquitin and the proteasome [J]. Nat Rev Mol Cell Biol, 2005, 6(1): 79-87.
[12]Ciechanover A, Kwon YT. Degradation of misfolded proteins in neurodegenerative diseases: Therapeutic targets and strategies [J]. Exp Mol Med, 2015, 47(3): e147. |